313 related articles for article (PubMed ID: 33947038)
1. Effects of TGF-β1 Receptor Inhibitor GW788388 on the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells.
Lho Y; Do JY; Heo JY; Kim AY; Kim SW; Kang SH
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947038
[TBL] [Abstract][Full Text] [Related]
2. Histone acetyltransferase inhibitor C646 reverses epithelial to mesenchymal transition of human peritoneal mesothelial cells via blocking TGF-β1/Smad3 signaling pathway in vitro.
Yang Y; Liu K; Liang Y; Chen Y; Chen Y; Gong Y
Int J Clin Exp Pathol; 2015; 8(3):2746-54. PubMed ID: 26045780
[TBL] [Abstract][Full Text] [Related]
3. Paricalcitol ameliorates epithelial-to-mesenchymal transition in the peritoneal mesothelium.
Kang SH; Kim SO; Cho KH; Park JW; Yoon KW; Do JY
Nephron Exp Nephrol; 2014; 126(1):1-7. PubMed ID: 24458092
[TBL] [Abstract][Full Text] [Related]
4. TGF-β1 Receptor Inhibitor SB525334 Attenuates the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells via the TGF-β1 Signaling Pathway.
Heo JY; Do JY; Lho Y; Kim AY; Kim SW; Kang SH
Biomedicines; 2021 Jul; 9(7):. PubMed ID: 34356903
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis.
Petersen M; Thorikay M; Deckers M; van Dinther M; Grygielko ET; Gellibert F; de Gouville AC; Huet S; ten Dijke P; Laping NJ
Kidney Int; 2008 Mar; 73(6):705-15. PubMed ID: 18075500
[TBL] [Abstract][Full Text] [Related]
6. Arctigenin alleviates TGF-β1-induced epithelial-mesenchymal transition and PAI-1 expression via AMPK/NF-κB pathway in peritoneal mesothelial cells.
Jin G; Su Y; Dong Q; Zhao X; Zhang L; Yan X
Biochem Biophys Res Commun; 2019 Dec; 520(2):413-419. PubMed ID: 31607474
[TBL] [Abstract][Full Text] [Related]
7. Effects of dexamethasone on the TGF-β1-induced epithelial-to-mesenchymal transition in human peritoneal mesothelial cells.
Jang YH; Shin HS; Sun Choi H; Ryu ES; Jin Kim M; Ki Min S; Lee JH; Kook Lee H; Kim KH; Kang DH
Lab Invest; 2013 Feb; 93(2):194-206. PubMed ID: 23207448
[TBL] [Abstract][Full Text] [Related]
8. Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.
Shi Y; Tao M; Wang Y; Zang X; Ma X; Qiu A; Zhuang S; Liu N
J Pathol; 2020 Jan; 250(1):79-94. PubMed ID: 31579944
[TBL] [Abstract][Full Text] [Related]
9. Endoplasmic reticulum stress as a novel target to ameliorate epithelial-to-mesenchymal transition and apoptosis of human peritoneal mesothelial cells.
Shin HS; Ryu ES; Oh ES; Kang DH
Lab Invest; 2015 Oct; 95(10):1157-73. PubMed ID: 26192086
[TBL] [Abstract][Full Text] [Related]
10. MiR-200a negatively regulates TGF-β
Guo R; Hao G; Bao Y; Xiao J; Zhan X; Shi X; Luo L; Zhou J; Chen Q; Wei X
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1087-F1095. PubMed ID: 29357421
[TBL] [Abstract][Full Text] [Related]
11. Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway.
Zhang Y; Huang Q; Chen Y; Peng X; Wang Y; Li S; Wu J; Luo C; Gong W; Yin B; Xiao J; Zhou W; Peng F; Long H
Int Immunopharmacol; 2020 Jan; 78():106064. PubMed ID: 31838448
[TBL] [Abstract][Full Text] [Related]
12. Asiaticoside inhibits TGF-β1-induced mesothelial-mesenchymal transition and oxidative stress via the Nrf2/HO-1 signaling pathway in the human peritoneal mesothelial cell line HMrSV5.
Zhao J; Shi J; Shan Y; Yu M; Zhu X; Zhu Y; Liu L; Sheng M
Cell Mol Biol Lett; 2020; 25():33. PubMed ID: 32514269
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor {beta}1 induces epithelial-mesenchymal transition by activating the JNK-Smad3 pathway in rat peritoneal mesothelial cells.
Liu Q; Mao H; Nie J; Chen W; Yang Q; Dong X; Yu X
Perit Dial Int; 2008 Jun; 28 Suppl 3():S88-95. PubMed ID: 18552272
[TBL] [Abstract][Full Text] [Related]
14. Nitro-oleic acid inhibits the high glucose-induced epithelial-mesenchymal transition in peritoneal mesothelial cells and attenuates peritoneal fibrosis.
Su W; Wang H; Feng Z; Sun J
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F457-F467. PubMed ID: 31760768
[TBL] [Abstract][Full Text] [Related]
15. Blockade of thrombospondin-1 ameliorates high glucose-induced peritoneal fibrosis through downregulation of TGF-β1/Smad3 signaling pathway.
Jiang N; Zhang Z; Shao X; Jing R; Wang C; Fang W; Mou S; Ni Z
J Cell Physiol; 2020 Jan; 235(1):364-379. PubMed ID: 31236971
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling.
Ueno T; Nakashima A; Doi S; Kawamoto T; Honda K; Yokoyama Y; Doi T; Higashi Y; Yorioka N; Kato Y; Kohno N; Masaki T
Kidney Int; 2013 Aug; 84(2):297-307. PubMed ID: 23486522
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming of Mesothelial-Mesenchymal Transition in Chronic Peritoneal Diseases by Estrogen Receptor Modulation and TGF-β1 Inhibition.
Wilson RB; Archid R; Reymond MA
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32532126
[TBL] [Abstract][Full Text] [Related]
18. Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells.
Zhang J; Thorikay M; van der Zon G; van Dinther M; Ten Dijke P
J Vis Exp; 2020 Oct; (164):. PubMed ID: 33191940
[TBL] [Abstract][Full Text] [Related]
19. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
[TBL] [Abstract][Full Text] [Related]
20. Functional molecules in mesothelial-to-mesenchymal transition revealed by transcriptome analyses.
Namvar S; Woolf AS; Zeef LA; Wilm T; Wilm B; Herrick SE
J Pathol; 2018 Aug; 245(4):491-501. PubMed ID: 29774544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
